Histological examination of biopsies confirms the diagnosis of idiopathic di lated cardiomyopathy but provides little insight in prognosis. Therefore, we studied if histochemical examination of biopsies had additional prognostic value. From 31 pts biopsies were obtained during catheterization. By light and electron microscopy subendocardial/interstitial fibrosis, myofibrlltolysis, mitochondrial degeneration, steatosis and vacuolar dystrophy were deter mined as was the activity of the enzymes SDH, HBDH, NADH-Trand LDH as markers of fundamental metabolic processes. Each histologic change was graded 1-3 (histo-score), according to the affected area (< 5%» 5-25%, > 25%). The enzyme activity was scored 1-3 (enzyme-score) for mild, mod erate, severe decrease. Pts were divided based on histo-score (< 7 and > 7) and enzyme-score (< 5 and > 5). Survival curves are shown below (histo-group left, enzyme-group to the right). 
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Combination of the data resulted in a significant difference in survival (p *= 0.016). All pts with histo-score > 7 and enzyme-score > 5 died within a year. Thus, morphological and histochemical analysis of biopsies in idiopathic dilated cardiomyopathy is a powerful prognostic indicator and might help select pts for cardiac transplantation. The role of endomyocardial biopsy (EMB) in the diagnostic and functional evaluation of dilated cardiomyopathy (DCM) pts is still an issue for debate. To evaluate the diagnostic yield of EMB histology and importance of my ocardial catecholamine (MCC) measurements in DCM, we studied 92 pts, 82,8% males, mean age 45.9 ± 10.9 years. At the initial assessment all pts underwent cardiac catheterization, measurements of related hemodynamic parameters and EMB. Flesults of EMB histology revealed both a new, unsus pected diagnosis and etiology in 31 pts (33.7%). Among them, myocarditis was found in 25 pts (27.2%), and specific heart muscle disease in 6 pts (6.5%) (hemochromatosis in 3, eosinophilic heart disease in 2, glycogenosis in I). Clinical diagnosis was confirmed in 57 pts (61.9%), while EMB did not pro vide useful information in 4 pts (4.3%). Myocardial norepinephrine (MNEC), epinephrine (MEC), and dopamine (MDC) concentrations were measured in EMB samples using catechoI-O-methyl-transferase radioenzymatic method in 32/92 DCM pts. The following mean values were found for MNEC: 262,2 ± 68,9 (ng/g of fresh myocardial tissue {ft}), MEC: 36.9 ± 7.1 ng/g ft, and MDC; 72.6 ±12.1 ng/g ft. The significant correlation was shown among MCC and LV hemodynamic parameters: In addition, we analyzed the effect of MNEC and MEC on the long term survival of 31 DCM pts. Survival (18/31) was significantly better in pts with higher MNEC (411.8 ± 43.4 survivors vs. 278.5 ± 75.7 non-survivors, p < 0,01) and MEC (55.3 ± 4.5 survivors vs. 39.2 ± 9.3 non-survivors, p < 0.01).
Univariate and multivariate analysis demonstrated that both MNEC and MEC predicted long-term survival independently and their low initial concen trations were associated with increased mortality.
Thus, EMB was shown to be useful not only in diagnostic but also in func tional and prognostic evaluation of pts presenting as DCM. MCC assessment can significantly broaden the spectrum of EMB usefulness.
11:15 The Significance of Anti-/3i-Adrenoceptor Autoantibodies in the Recovery From Dilated Cardiomyopathy
Johannes Mueller, Gerd Wallukat1, Yu-Guo Weng, Henryk Slniwaski, Ulrike Ziegler, Michael Dandel, Roland Hetzer. German Heart Institute Berlin; 1 Max-Delbrueck-Center, Berlin, Germany Between April 1994 and May 1995, 16 patients with endstage idiopathic di lated cardiomyopathy were implanted with a left ventricular assist device after conservative pharmacological therapy failed. A pathologic level of autoanti bodies directed against r adrenoceptors (AAB) as measured by a bioassay was observed in the sera of 14 patients (the sera of 2 patients were not examined). Left ventricular internal diameter in diastole (LVIDd) was greater than 70 mm and ejection fraction (EF) below 15% in all patients at time of device implantation. Eight patients died within 3 months after implantation. In the remaining 8 the AABs dropped continuously until they completely disap peared within 3 months of mechanical cardiac support. Cardiac function also improved to nearly normal In 4 of the 8 patients whose LVIDd were below 74 mm. Mean LVIDd and EF levels reached 52 ±4.1 mm (range, 48 to 56 mm) and 48.8 ± 4.8% (range, 45 to 55%), respectively. Consequently, three patients (one patient did not agree to this procedure) were weaned from the implanted device after 160, 244, and 347 days support, respectively. The first patient Is now off the device since 180, the second since 91, and the third since 84 days. All patients exhibit unchanged functional parameters and show no repeat increase in AAB level. Hypothesizing that AABs indicate an autoimmunological process which may take part in cardiac dilatation and functional impairment, weaning from the assist device seems possible as long as cardiac function has improved and the AABs have disappeared.
11:30 ACE-lnhibitor Improves Autonomic Nervous Abnormalities in Dilated Cardiomyopathy
Fumiyasu Yamasaki, Jun Takata, Takashi Furuno, Taishlro Chikamori, Takayuki Sato, Masahide Sasaki, Yoshinori Doi. Kochi Medical School, Kochi, Japan To evaluate the effects of ACE-inhibitor (ACEI) on autonomic nervous activity in patients with dilated cardiomyopathy (DCM), 11 DCM pts (NYHA ll-III, LVEF16-49%, 59 ± 8 yrs) and 10 normal subjects (51 ± 1 6 yrs) were stud ied by spectral analysis of both arterial pressure and heart rate fluctuations. Arterial pressure and ECG were continuously recorded in a supine position with controlled respiration (0.2 Hz). Low frequency and high frequency com ponents of the beat-to-beat fluctuations of systolic arterial pressure (SAP) and RR interval (RR) ware then estimated by autoregressive component power spectral analysis. Results; (1) The LF power (normalized unit) of RR
